Shaanxi University of Science and Technology

Shaanxi Panlong Pharmaceutical Co., Ltd.

Xi'an Taikomed Pharmaceutical Technology Co., Ltd.

Xuechuan Wang

Chengyuan Liang

Han Li

Danni Tian

Minyi Jia

Lei Tian

Dezhu Zhang

Xiaolin Xie

Taotao Qiang

Xingke Ju

Juan Xia

Xinhua Liu

Ouyang Yue

Qianqian Zhao

Jingyi Li

Liang Xin

Yuzhi Liu

Yonghong Tang

Minghui Chang

Shunjun Ding

Nan Qin

Zhao Ma

Kangxiong Wu

Xuhua Zhou

Shaojun Zhang

Jie Li

Songsong Ruan

Zhenfeng Shi

Kaiqi Shi

Mengdi Hou

Qingbo Zhao

Min Li

Manhui Zheng

Catherine J Lee

Maggie Lewis

Wei Liu

Bin Tian

Juan Li

Xuefeng Chen

Longfang Ren

Xeufeng Chen

Lili Wen

Weihui Ju

Guang Tong

Youyou Wang

Xing Zhu

Qingxin Han

Yanmei Xing

Ji Li

Na Xu

Huijie Zhang

A method of preparing a vinyl collagen microsphere polyamide fiber composite material includes the following steps: step 1: modifying a collagen with methacrylic anhydride to obtain a vinyl collagen, then emulsifying and cross-linking the vinyl collagen to obtain vinyl collagen microspheres; step 2: treating a polyamide fiber substrate with formaldehyde to obtain a hydroxylated polyamide fiber substrate, treating the hydroxylated polyamide fiber with (3-mercaptopropyl)trimethoxysilane (MPS) to obtain a sulfhydrylated polyamide fiber substrate; and step 3: modifying the sulfhydrylated polyamide fiber substrate with the vinyl collagen microspheres to obtain the vinyl collagen microsphere polyamide fiber composite material.

Method of preparing vinyl collagen microsphere polyamide fiber composite material

A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. The Linker is or and n is 1-6.

Protacs targeting coronavirus 3CL protease and preparation method and application thereof

A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. In formula I and II, n is 1-6.

Protacs based on VHL ligand targeting coronavirus 3CL protease and preparation method and application thereof

A method for preparing a conductive biomimetic skin scaffold material with self-repairing function includes the following steps: adding 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to a homogeneous dispersion of acidified carbon nanotubes, poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS), and gelatin to cross-link to obtain a conductive composite colloid; and injecting the conductive composite colloid into a mold, aging at &#x2212;4-4&#xb0; C. for 12-24 hours, and then soaking in a phosphate-buffered saline (PBS) solution with a pH of 7.0-7.4 for 12-24 hours to obtain the conductive biomimetic skin scaffold material.

Conductive biomimetic skin scaffold material with self-repairing function and a method of preparing the same

A method for preparing a collagen from a chromium-containing tanned leather waste is disclosed. The method includes acid dechromation, obtaining a collagen aggregate, and converting the collagen aggregate to the collagen. The method also includes a reaction in a supercritical carbon dioxide reactor.

Method for preparing collagen aggregate and collagen from chromium-containing tanned leather wastes by combined acid-enzyme controlled degradation technology

A method of preparing an aesculin sturgeon skin gelatin with antioxidant activity anddetection ability includes: 1) mixing a sturgeon skin gelatin and distilled water in a ratio of 1:15-1:25 (w/v) at 50-70&#xb0; C. and filtering to obtain a sturgeon skin gelatin solution; 2) adding aesculin and a glycerin solution to the sturgeon skin gelatin solution, stirring the resulted sturgeon skin gelatin solution at 30-50&#xb0; C. for 30 minutes, and filtering; and 3) removing air bubbles from the sturgeon skin gelatin solution of step 2) under reduced pressure, placing the sturgeon skin gelatin solution on an acrylic glass, and drying the sturgeon skin gelatin solution at in a vented oven 25&#xb0; C. and 45-55% relative humidity for 24 hours to obtain the aesculin sturgeon skin gelatin film.

Aesculin sturgeon skin gelatin film with antioxidant activity and enterococcus faecalis detection ability and a method of preparing the same

A compound having the formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Bergenin lipoic acid ester with antioxidant activity and a method of preparing the same

A compound having the following formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Bergenin thiodipropionic acid ester with antioxidant activity and a method of improving the antioxidant property of ganoderma lucidum spore oil using the same

A method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine includes: reacting guanidine hydrochloride with ethyl carbamoylacetate and sodium hypochlorite in the presence of a metal nitrate salt and acetate anhydride in an organic solvent. 

Method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine and its application thereof

A compound having the following formula I: In formula I, Rand Rare independently H, alkyl, alkoxy, and halogen. A method of preparing the compound of formula I is also disclosed.

13-hydroxysparteine cinnamic acid derivatives with anti-tumor activities and a method of preparing the same

A method of preparing a sturgeon skin gelatin with antioxidant activity includes: 1) soaking sturgeon skin in water, and sonicating the sturgeon skin; 2) cutting the sturgeon skin, soaking the sturgeon skin in a NaOH solution, and soaking the sturgeon skin in an HCl solution; 3) washing the sturgeon skin of step 2) to neutral, placing the sturgeon skin in an extraction solution for extracting sturgeon skin protein; and 4) obtaining the sturgeon skin gelatin. A method of preparing a sturgeon skin gelatin film includes: 1) dissolving sturgeon skin gelatin in water to obtain a sturgeon skin gelatin solution; 2) adding glycerine to the sturgeon skin gelatin solution; and 3) obtaining the sturgeon skin gelatin film.

Method of preparing sturgeon skin gelatin and sturgeon skin gelatin film with antioxidant activity

A compound with antitumor activities is represented by formula A or formula B R, R, R, and Rare independently hydrogen, hydroxyl, alkoxy, halogen, formyl, unsubstituted or substituted alkyl, or unsubstituted or substituted cycloalkyl.

Coumarin-gossypol derivatives with antitumor activities and a method of preparing the same

A compound with antitumor activities represented by formula I: In formula I, Ris alkyl, alkoxy, or ethenyl; and Ris alkyl, alkoxy, or halogen.

Edaravone-gossypol derivatives with antitumor activities and a method of preparing the same

A compound with antitumor activities is represented by formula: R, R, R, and Rare independently hydrogen, nitro, alkoxy, halogen, unsubstituted or substituted phenyl, or unsubstituted or substituted alkyl or cycloalkyl.

Asymmetric 7-N isatin dimer Schiff base compounds with antitumor activities and a method of preparing the same

Growing community of inventors

Xi'an, China

Xuechuan Wang